Treos Bio Company

Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.

Headquarters: London, England, United Kingdom
Investors Number: 4
Last Funding Type: Convertible Note
Funding Status: Early Stage Venture
Employee Number: 1-10
Total Funding: 38363455
Last Funding Date: 2021-03-31
Founded Date: 2013-01-01
Industry: Peptides and Proteins
Estimated Revenue: $1M to $10M